REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $48,124 | +17.4% | 2,284 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $40,998 | +9.1% | 2,284 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $37,595 | -17.7% | 2,284 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $45,657 | +5.7% | 2,284 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $43,190 | -29.4% | 2,284 | -15.3% | 0.00% | -33.3% |
Q4 2022 | $61,191 | -14.2% | 2,698 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $71,308 | +7.0% | 2,698 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $66,641 | -25.6% | 2,698 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $89,547 | -75.1% | 2,698 | -75.5% | 0.00% | -40.0% |
Q4 2021 | $359,471 | -22.0% | 10,993 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $460,827 | +7.9% | 10,993 | 0.0% | 0.01% | +16.7% |
Q2 2021 | $427,078 | +19.6% | 10,993 | +5.0% | 0.01% | +20.0% |
Q1 2021 | $357,063 | -25.3% | 10,468 | -0.7% | 0.01% | -28.6% |
Q4 2020 | $478,094 | +64.8% | 10,540 | 0.0% | 0.01% | +40.0% |
Q3 2020 | $290,061 | -25.3% | 10,540 | 0.0% | 0.01% | -28.6% |
Q2 2020 | $388,188 | +10.6% | 10,540 | -2.8% | 0.01% | 0.0% |
Q1 2020 | $351,064 | -21.0% | 10,842 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $444,197 | +10.4% | 10,842 | -4.0% | 0.01% | 0.0% |
Q3 2019 | $402,244 | -23.7% | 11,299 | +10.1% | 0.01% | -22.2% |
Q2 2019 | $527,005 | -10.4% | 10,259 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $587,943 | +36.6% | 10,259 | 0.0% | 0.01% | +22.2% |
Q4 2018 | $430,365 | -44.4% | 10,259 | 0.0% | 0.01% | -35.7% |
Q3 2018 | $774,555 | -99.9% | 10,259 | +10.6% | 0.01% | +27.3% |
Q2 2018 | $665,409,000 | +140.4% | 9,274 | 0.0% | 0.01% | +175.0% |
Q1 2018 | $276,829,000 | +95358.3% | 9,274 | +6.2% | 0.00% | 0.0% |
Q4 2017 | $290,000 | -52.5% | 8,733 | -52.8% | 0.00% | 0.0% |
Q3 2017 | $610,000 | +86.0% | 18,500 | +11.5% | 0.00% | +100.0% |
Q2 2017 | $328,000 | +2.5% | 16,595 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $320,000 | +3.9% | 16,595 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $308,000 | +32.8% | 16,595 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $232,000 | +70.6% | 16,595 | -2.3% | 0.00% | +100.0% |
Q2 2016 | $136,000 | – | 16,982 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
Atom Investors LP | 36,487 | $901,000 | 0.39% |